Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a study

Autor: Kelly, Kevin R *, Ailawadhi, Sikander, Siegel, David S, Heffner, Leonard T, Somlo, George, Jagannath, Sundar, Zimmerman, Todd M, Munshi, Nikhil C, Madan, Sumit, Chanan-Khan, Asher, Lonial, Sagar, Chandwani, Suraj, Minasyan, Ashot, Ruehle, Markus, Barmaki-Rad, Farima, Abdolzade-Bavil, Afsaneh, Rharbaoui, Faiza, Herrmann-Keiner, Eva, Haeder, Thomas, Wartenberg-Demand, Andrea, Anderson, Kenneth C
Zdroj: In The Lancet Haematology November 2021 8(11):e794-e807
Databáze: ScienceDirect